NCT03598595: Gemcitabine, Docetaxel, and Hydroxychloroquine in Treating Participants With Recurrent or Refractory Osteosarcoma
- State
- Under way
- Phase
- Phase 1 and Phase 2
- People
- 31 taking part
- Started
- 28 Jan 2019
- Primary completion
- 31 May 2027
- Arms
- Treatment (hydroxychloroquine, gemcitabine, docetaxel)
- Results
- None posted
- 26 Jul 2018: Trial registered
- 28 Jan 2019: Trial started